Aytu Biopharma Inc
F:AY20
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aytu Biopharma Inc
F:AY20
|
US |
|
R
|
Ross Stores Inc
SWB:RSO
|
US |
|
secunet Security Networks AG
F:YSN
|
DE |
|
Sandvik AB
F:SVK
|
SE |
|
L
|
Lam Research Corp
SWB:LAR
|
US |
|
P
|
Pearson PLC
F:PES
|
UK |
|
A
|
AP Moeller - Maersk A/S
XBER:DP4B
|
DK |
|
Donskoy Zavod Radiodetaley OAO
MOEX:DZRD
|
RU |
|
flatexDEGIRO AG
F:FTK
|
DE |
|
N
|
Nippon Sheet Glass Co Ltd
DUS:NI9
|
JP |
|
M
|
Mebuki Financial Group Inc
F:5EE
|
JP |
|
Sinopharm Group Co Ltd
F:X2S1
|
CN |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
Bankruptcy Probability
Aytu Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aytu Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
27.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
913.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
539.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
279.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
217.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aytu Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aytu Biopharma Inc has total debt of 19.1m USD. This includes both short-term (9.1m USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
